Collagen formation and degradation increase during growth hormone therapy in children

Bone

Volumn 20, Issue 2, 1997, Pages 133-138

  Vihervuori, Elina ^a   Turpeinen, M ^a   Siimes, M A ^a   Koistinen, H ^a   Sorva, R ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Bone metabolism; Children; Insulin like growth factor; Insulin like growth factor binding protein; Osteocalcin; Procollagen

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GROWTH HORMONE; OSTEOCALCIN; PROCOLLAGEN; SOMATOMEDIN BINDING PROTEIN 3;

ARTICLE; CHILD; CLINICAL ARTICLE; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; FEMALE; GROWTH HORMONE RELEASE; GROWTH RATE; HORMONAL THERAPY; HUMAN; LONGITUDINAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SHORT STATURE;

ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BODY HEIGHT; CHILD; COLLAGEN; FEMALE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; OSTEOCALCIN;

EID: 0031080906     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(96)00332-8     Document Type: Article

References (31)

1. 1. The Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Pathology. Recommended methods for determinations of four enzymes in blood. Scand J Clin Lab Invest 33:291-306; 1974.
2. 2. Bergmann, P., Valsamis, J., Van Perborgh, J., De Schepper, J., and Van Vliet, G. Comparative study of the changes in insulin-like growth factor-I, procollagen-III N-terminal extension peptide, bone gla-protein, and bone mineral content in children with Turner's syndrome treated with recombinant growth hormone. J Clin Endocrinol Metab 71:1461-1467; 1990.
3. 3. Beshyah, S. A., Thomas, E., Kyd, P., Sharp, P., Fairney, A., and Johnston, D. G. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism. Clin Endocrinol (Oxf) 40:383-391; 1994.
4. 4. Blum, W. F. and Ranke, M. B. Use of insulin-like growth factor-binding protein 3 for the evaluation of growth disorders, Horm Res 33 (Suppl. 4):31-37; 1990.
5. 5. Canalis, E., Rydziel, S., Delany, A. M., Varghese, S., and Jeffrey, J. J. Insulin-like growth factors inhibit interstitial collagenase synthesis in bone cell cultures. Endocrinology 136:1348-1354; 1995.
6. 6. Danne, T., Grüters, A., Schuppan, D., Quantas, N., Enders, I., and Weber, B. Relationship of procollagen type III propeptide-related antigens in serum to somatic growth in healthy children and patients with growth disorders. J Pediatr 114:257-260; 1989.
7. 7. Delmas, P. D. Clinical use of biochemical markers of bone remodelling in osteoporosis. Bone 13:17-21; 1992.
8. 8. Eriksen, E. F., Charles, P., Melsen, F., Mosekilde, L., Risteli, L., and Risteli, J. Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry. J Bone Miner Res 8:127-132; 1993.
9. 9. Furlanetto, R. W. Insulin-like growth factor measurements in the evaluation of growth hormone secretion. Horm Res 33 (Suppl. 4):25-30; 1990.
10. 10. Hyams, J. S., Treem, W. R., Carey, D. E., Wyzga, N., Eddy, E., Goldberg, B. D., and Moore, R. Comparison of collagen propeptides as growth markers in children with inflammatory bowel disease. Gastroenterology 100:971-975; 1991.
11. 11. Johansson, A. G., Forslund, A., Hambraeus, L., Blum, W. F., and Ljunghall, S. Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men. J Bone Miner Res 9:915-921; 1994.
12. 12. Jones, J. I. and Clemmons, D. R. Insulin-like growth factors and their binding proteins: Biological actions. Endocrinol Rev 16:3-34; 1995.
13. 13. Koistinen, H., Seppälä, M., and Koistinen, R. Different forms of insulin-like growth factor-binding protein-3 detected in serum and seminal plasma by immunofluorometric assay with monoclonal antibodies. Clin Chem 40:531-536; 1994.
14. 14. Melkko, J., Niemi, S., Risteli, L., and Risteli, J. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 36:1328-1332; 1990.
15. 15. O'Halloran, D. J., Tsatsoulis, A., Whitehouse, R. W., Holmes, S. J., Adams, J., and Shalet, S. M. Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 76:1344-1348; 1993.
16. 16. Penttilä, I. M., Jokela, H. A., Viitala, A. J., Heikkinen, E., Nummi, S., Pystynen, P., and Saastamoinen, J. Activities of aspartate and alanine aminotransferases and alkaline phosphatase in sera of healthy subjects. Scand J Clin Lab Invest 35:275-284; 1975.
17. 17. Price, P. A., Parthemore, J. G., and Deftos, L. J. New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone gla protein in the plasma of normal subjects and patients with bone disease. J Clin Invest 66:878-883; 1980.
18. 18. Prockop, D. J., Kivirikko, K. I., Tuderman, L., and Guzman, N. A. The biosynthesis of collagen and its disorders. New Engl J Med 301:13-23; 1979.
19. 19. Risteli, J., Elomaa, I., Niemi, S., Novamo, A., and Risteli, L. Radioimmunoassay for the pyridonoline cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin Chem 39: 635-640; 1993.
20. 20. Risteli, J., Niemi, S., Trivedi, P., Mäentausta, O., Mowat, A. P., and Risteli, L. Rapid equilibrium radioimmunoassay for the aminoterminal propeptide of human type III procollagen. Clin Chem 34:715-718; 1988.
21. 21. Saggese, G., Baroncelli, G. I., Bertelloni, S., Cinquanta, L., and Di Nero, G. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr 122:37-45; 1993.
22. 22. Saggese, G., Baroncelli, G. I., Bertelloni, S., Cinquanta, L., and Di Nero, G. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children. Pediatr Res 35:409-415; 1994.
23. 23. Saggese, G., Bertelloni, S., Baroncelli, G. I., and Di Nero, G. Serum levels of carboxyterminal propeptide of type I procollagen in healthy children from first year of life to adulthood and in metabolic bone diseases. Eur J Pediatr 151: 564-568; 1992.
24. 24. Sartorio, A., Conti, A., Monzani, M., Morabito, F., and Faglia, G. Growth hormone treatment in adults with GH deficiency: Effects on new biochemical markers of bone and collagen turnover. J Endocrinol Invest 16:893-898; 1993.
25. 25. Sorva, R., Tolppanen, E. M., and Perheentupa, J. Variation of growth in height and weight of children. Acta Paediatr Scand 79:498-506; 1990.
26. 26. Stein, G. S., Lian, J. B., and Owen, T. A. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentation. FASEB J 4:3111-3123; 1990.
27. 27. Tapanainen, P., Risteli, L., Knip, M., Käär, M. L., and Risteli, J. Serum aminoterminal propeptide of type III procollagen: A potential predictor of the response to growth hormone therapy. J Clin Endocrinol Metab 67:1244-1249; 1988.
28. 28. Trivedi, P., Risteli, J., Risteli, L., Hindmarsh, P. C., Brook, C. G. D., and Mowat, A. P. Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders. Pediatr Res 30:276-280; 1991.
29. 29. Vandeweghe, M., Taelman, P., and Kaufman, J.-M. Short- and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol 39:409-415; 1993.
30. 30. Vihervuori, E., Virtanen, M., Koistinen, H., Koistinen, R., Seppälä, M., and Siimes, M. A. Hemoglobin level is linked to growth hormone-dependent proteins in short children. Blood 87:2075-2081; 1996.
31. 31. Zamboni, G., Antoniazzi, F., Radetti, G., Musumeci, C., and Tatò, L. Effect of two different regimens of recombinant human growth hormone therapy on the bone mineral density of patients with growth hormone deficiency. J Pediatr 119:483-485; 1991.